|
TBCC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.15759998545684E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.43529649171614E-11 |
| Normal-vs-Stage2 |
2.180400E-01 |
| Normal-vs-Stage3 |
5.942800E-03 |
| Normal-vs-Stage4 |
7.136500E-03 |
| Stage1-vs-Stage2 |
1.138160E-03 |
| Stage1-vs-Stage3 |
2.496900E-03 |
| Stage1-vs-Stage4 |
2.104100E-03 |
| Stage2-vs-Stage3 |
4.070800E-01 |
| Stage2-vs-Stage4 |
4.084200E-01 |
| Stage3-vs-Stage4 |
9.608200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.1707999971824E-08 |
| Normal-vs-AfricanAmerican |
1.384740E-03 |
| Normal-vs-Asian |
3.004200E-01 |
| Caucasian-vs-AfricanAmerican |
6.343800E-02 |
| Caucasian-vs-Asian |
9.740600E-01 |
| AfricanAmerican-vs-Asian |
4.910400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08080000005284E-06 |
| Normal-vs-Female |
4.61060001288871E-09 |
| Male-vs-Female |
3.610200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.590370E-02 |
| Normal-vs-Age(41-60Yrs) |
8.37620000027073E-08 |
| Normal-vs-Age(61-80Yrs) |
4.84170000003559E-06 |
| Normal-vs-Age(81-100Yrs) |
8.544400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.562000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.770800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.464200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.832400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.632200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.063400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.73360004129819E-09 |
| Normal-vs-Grade 2 |
4.11890521689884E-11 |
| Normal-vs-Grade 3 |
3.8371000000037E-05 |
| Normal-vs-Grade 4 |
8.233800E-01 |
| Grade 1-vs-Grade 2 |
1.967790E-02 |
| Grade 1-vs-Grade 3 |
4.879400E-03 |
| Grade 1-vs-Grade 4 |
8.62810000001879E-07 |
| Grade 2-vs-Grade 3 |
2.569200E-01 |
| Grade 2-vs-Grade 4 |
1.78119999860726E-08 |
| Grade 3-vs-Grade 4 |
2.965200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.77076189453874E-15 |
| Normal-vs-ccB subtype |
8.944000E-02 |
| ccA subtype-vs-ccB subtype |
3.417900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.24350000000073E-05 |
| Normal-vs-N1 |
7.649000E-01 |
| N0-vs-N1 |
1.069250E-01 |
|
|
